Antares Pharma, Inc. (ATRS)

[tjguy]

At the time, I didn't think much of it, but NOW, I'm a bit suspicious of this sale!

From today's news release:

"On September 22, 2017, the Company received labeling comments from the FDA which the Company responded to on September 29, 2017."

My guess is that from this communication, suspicions began to rise at the company.

IF SO, it would seem that this insider trade was border line illegal.

I'm obviously disappointed because the trial results were excellent. They still have other drugs with PDUFAs coming up so I'm not selling. In fact, if it falls significantly tomorrow, I may pick up some more shares.